KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Long-Term Investments: 2021-2023

Historic Long-Term Investments for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Dec 2023 value amounting to $78.6 million.

  • Ginkgo Bioworks Holdings' Long-Term Investments fell 29.97% to $78.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $78.6 million, marking a year-over-year decrease of 29.97%. This contributed to the annual value of $78.6 million for FY2023, which is 29.97% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Long-Term Investments stood at $78.6 million for FY2023, which was down 29.97% from $112.2 million recorded in FY2022.
  • Ginkgo Bioworks Holdings' 5-year Long-Term Investments high stood at $112.2 million for FY2022, and its period low was $78.6 million during FY2023.
  • For the 3-year period, Ginkgo Bioworks Holdings' Long-Term Investments averaged around $97.6 million, with its median value being $102.0 million (2021).
  • Its Long-Term Investments has fluctuated over the past 5 years, first grew by 9.95% in 2022, then fell by 29.97% in 2023.
  • Over the past 3 years, Ginkgo Bioworks Holdings' Long-Term Investments (Yearly) stood at $102.0 million in 2021, then rose by 9.95% to $112.2 million in 2022, then fell by 29.97% to $78.6 million in 2023.